|
gptkbp:instanceOf
|
gptkb:biotechnology
gptkb:public_company
|
|
gptkbp:CEO
|
gptkb:Emma_Walmsley
|
|
gptkbp:country
|
gptkb:United_Kingdom
|
|
gptkbp:divested
|
Haleon (consumer healthcare spin-off, 2022)
|
|
gptkbp:founded
|
2000
|
|
gptkbp:headquartersLocation
|
Brentford, London, United Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
GlaxoSmithKline UK
|
|
gptkbp:industry
|
gptkb:biotechnology
healthcare
pharmaceuticals
|
|
gptkbp:ISIN
|
GB0009252882
|
|
gptkbp:keyPerson
|
gptkb:Emma_Walmsley
|
|
gptkbp:memberOf
|
gptkb:FTSE_100_Index
|
|
gptkbp:notableProduct
|
gptkb:Sensodyne
gptkb:Advair
gptkb:Augmentin
gptkb:Shingrix
gptkb:Ventolin
gptkb:Panadol
|
|
gptkbp:numberOfEmployees
|
~70,000
|
|
gptkbp:parentCompany
|
gptkb:GlaxoSmithKline_plc
|
|
gptkbp:predecessor
|
gptkb:Glaxo_Wellcome
gptkb:SmithKline_Beecham
|
|
gptkbp:products
|
vaccines
pharmaceutical drugs
consumer healthcare products
|
|
gptkbp:revenue
|
£29.3 billion (2023)
|
|
gptkbp:stockExchange
|
gptkb:London_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:GSK
|
|
gptkbp:subsidiary
|
gptkb:Stiefel_Laboratories
gptkb:ViiV_Healthcare
|
|
gptkbp:website
|
https://www.gsk.com/
|
|
gptkbp:bfsParent
|
gptkb:M4_corridor
|
|
gptkbp:bfsLayer
|
8
|